Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)

✍ Scribed by T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luft; I. Bruns; F. Zohren; C. Wolschke; R. Fenk; R. Haas; G. Kobbe

• Book ID: 116281998
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 63 KB
• Volume: 17
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2010.12.028